Member Info for gjbrandon

I have been less inclined to respond to opinion on the BB but sometimes it is important to fine tune those who do take the time and effort to post and I appreciate reading them.

I wish to point out the reference to Breath Test and timeline.

If you look at the Tax Credits in the 2021 Annual Report on page 43 you will see that R&D tax credits are £711,000 compared to £77,000 for the year 2020.

As the UK offers 33% tax credits, it is easy to calculate the investment by the Company in R&D in both the Microbiome and Modern Water equipment, Wich includes both the PD for water contamination and BT for the multiplex biomarker detection, of which SARS-CoV-2 is but one target pathogen. This is a digital health medical device and rolling it out for a single biomarker is not viable when it is to be used in a clinical diagnostic laboratory or eventually small enough to be used in an GP office.

That is nearly 10 times what was spent in R&D in 2020 Some of that is on BT. Progress is being made and while it may not be detecting COVID in test centers we are falling behind on delivery taking into account the time it takes to bring a medical device to market.

As a shareholder I am as frustrated as any shareholder, but the Company is growing at the pace it can considering the demands on products, equipment and services demanded in all the fast growth areas we operate in.

Just a quick one on the BT. It is very much at the forefront of our development programme. It is just that the BT comes after we reduce the PD units to miniature size and a cost. The exact same technology (single use, rather than a flow cell) is the only difference. It is coming and is expected to be able to diagnose multiple infectious diseases. In fact we had multiple meetings on this with our partners in Microsaic and Pulmobiomed last week and this morning

Some stats from the AGM Event.
199 attended the live event.
293 viewed the video after the event.
48 questions were asked (some were duplicates but all answered
164 responded to the poll

Just clarifying some disingenuous comments. All MSYS questions were answered and released to all those registered at the Investor Meet Company event.

Constant reference to death spiral debt with provider is inaccurate. The debt is a high-interest short-term loan, payable back in instalments from growth in revenues. No shares were issued in advance of receipt of the loan and no shares were issued to be sold into the market to the loan provider.

My understanding of what is termed a "death spiral loan" is that the shares are issued by a company, to the debt provider, ahead of the advance of funds. The company receives cash and the debt provider sells the shares into a rising market. This benefits a company where the share price is rising. The debtor has immediate cash and the debt provider sells into a rising market which is profitable.

DeepVerge merely took out a high-interest loan (not a bad decision in a high inflation market) to be paid back to the debt provider through instalments. Just to be very clear, no shares were provided to the debt provider and instalments pay the debt provider back from revenues with interest. This was done with the same debt provider successfully. It is worth re-reading the RNS on the conditions of the loan.

@T-rat the BT remains still in development mode as part of the digital health sector for multiple biomarkers and not part of COVID-19 only deployment. Resources are very much geared to current commercial scaling, but rest assured it is part of the growth mix of equipment to be rolled out, as a medical device.

@sipps No distributor buys £1m+ of product to stock. They are local tier 1 partners in their respective markets who have clients for the units.

Just like to reiterate what @dingdong mentioned. This is £3m for Modern Water only in China and Sth Asia, which is also only one division in one quarter, Q2 (3 month period). The entire sales for 2020 for 12 months was £4.4m.

@smeeno finally someone understands the business model re: margins on referrals and affiliate sales of recommended products that have been tested and listed on the SKIN Trust Club Marketplace. Skin Trust Club home test are not the product that is sold, it is the enabler of skincare companies to sell Labskin and Skin microbiome tested products, that have a positive impact for the Skin Trust Club member.

Compare that to every home test kit company, in the world right now. For every sale of their test, they have to spend money marketimg the benefit of their test. Skin Trust Club enables the consumer to have the best skin possible, giving that advice and app for free, and recommend scientifically, the best products for their skin.

The customer is the centre focus. The skin care manufacturer gets their product sold by the STC members own skin, so the customer is happy, Skin Trust Club earn a wholesale or affiliate fee in perpetuity like a loyalty card for every future product that matches the customers recommended report.

@Hutchy. In version 3 of the App, there will be dynamic ingredient matching to the users unique skin test report, so that a customer will be told whether that product is good or bad, even if it has not be tested on Labskin. The loyalty programs are not ours, but the drug store chains. Our service, which includes testing is provided via the drug store chains and their range of products are on the database.

It is important to understand that many products are slight variations of ones that have been tested on Labskin. This gives the version 3 App another dimension of support for personalisation of the skin care industry that is scientifically supported by the 15 years of aggregated knowledge in Labskin on ingredients tested for positive impact on skin microbiome.

Loyalty Programs:

A retail drug store has X million of loyalty customers who buy skin care products from them every month. They know the history of a buyers purchases and use trends to predict the type of products their customers are likely to buy, so make recommendations to the customer of likely similar products as people do like to try new products to see if they can improve their skin.

Skin Trust Club plus Drug Store loyalty programs can scientifically verify with a STC home test kit, exactly what ingredients and products the customer should have for the best outcome for their skin.

Now, the loyalty program will inform the customer what's right for their skin and thr loyalty card drug store owner becomes the hero, providing information and advice in the best interest of the customer, while selling their product. Everybody wins.

In addition, the drug store loyalty program now has so much more data on the profile of their loyalty card owners and can predict and recommend products based on season, ennviroent, medical conditions, age and advise as the loyalty card holder stays with the drug store.

Inventory is personalised to each drug store, region, state, leading to less warehouse stock with greater distribution efficiencies. There is so much additional benefits.

This is the B2B at retail drug store level. More revenue from more satisfied customers, more data to enarges the largest skin microbiome library in the world, more affiliate revenues from sales of skin care product, meeting Labskin test. Criteria for Skin Trust Club.

@trillsg these are repair and maintenance tender contracts.

@LTBeliever just for some clarity on his the combination of Labskin and Skin Trust Club works.

Labskin validates the skincare products that underpin the recommendations of products to Skin Trust Club members. This creates an entirely new marketplace for skin care manufacturers. The club members have their own skin translate the needs of the users Skin. Labskin conforms to the Club members that the products they are buying are goi g to have a positive impact on their skin (condition) microbiome. This in turn shows skin care manufacturers that they don't have to spend marketing money promoting their products. They just need to get their products tested on Labskin (for which they pay) to get on the Skin Trust Club Marketplace. One feeds on the other as more products get onto the platform the recommendations get better and so on and son feesi g each other

@Simongatte. If a single product or ingredient is to be tested, it goes through a range of testing protocols. Back, before Labskin provided third party scientific proof of the impact of a product on the Skin microbiome services, Labskin was just a product offered to skin care manufacturers research and development laboratories.

The services offered to clue ts can be for a single product, or as is the case with many large skin care companies involves multi-product and.multi-year framework agreements.

These agreements allow companies to have a range of products submitted and larger companies have been contributing 6 figure orders on a regular basis and are lilely to Co tjnje to do so throughout the lifetime of the framework agreements.

Working with many of the largest skin care corporations in the world, these amount are small by comparison to their marketing budget, but give these companies an important claim on their products ability to have a positive impact on the users Skin Microbiome.

The SkinTrustClub App is constantly evolving as new products and services come on stream.

French
Italian
Spanish
English
Arabic
Portuguese
Irish
Mandarin
Cantonese
Japanese
Polish
Czech
I am sure there is more, but those are the written and spoken languages that I am aware of in Labskin and Modern Water

Two fluent French and Italian speakers, one Spanish and all English speakers.

English is official language of In-Cosmetics events.

Labskin Team are at Cosmoprof in Bologna end of April. Native Italian speakers will be there as it is a bi-lingual event.

Modern Water is not a consultancy. Our interest would be in supplying materials for the mobile unit to be kitted out, not servicing equipment that is not Modern Water equipment.

What is going on in Ukraine is unbelievable. The world is a scary place and when things like this happen, people tend to derisk as fear sets in. I see the share price of the company and lots of shareholders have reached out and asked all sorts of questions, so as CEO and a fellow shareholder I want to reassure you that everything we have said continues to make progress. We will inform the market in due course, but nothing has changed from recent RNS and we are not affected by the geopolitical risks that have caused fear in the markets.

@T.Rat the objective remains the same

EcowaterOS is the consortium of large and small companies and with existing Brands belonging to each consortium member, it was agreed that the promotion of another Brand was unnecessary.

@StuofTheMoon, I may not be posting as much as usual but I am grateful for the support of all stakeholders. The Labskin department around the corner from you is working at full pace with PR programs underway this week and next for the Skin Trust Club. Thankfully post-COVID travelling is better for most divisions.

Do pass on my very best regards to your Mum this Sunday.